Page last updated: 2024-08-16

ribavirin and exudates

ribavirin has been researched along with exudates in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chew, NK; Chong, HT; Chua, KB; Goh, KJ; Kamarulzaman, A; Kunjapan, SR; Lam, SK; Tan, CT; Thayaparan, T1
Robert Ding, PH; Seow, EL1
Lee, HL; Phong, TV; Rohani, A1
Abu Hassan, MR; Gonzalez, YS; Ong, SC; Shafie, AA; Virabhak, S1

Trials

1 trial(s) available for ribavirin and exudates

ArticleYear
Pegylated interferon alfa-2b (peg-intron) plus ribavirin (rebetol) in the treatment of chronic hepatitis C: a local experience.
    The Medical journal of Malaysia, 2005, Volume: 60, Issue:5

    Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Malaysia; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2005

Other Studies

3 other study(ies) available for ribavirin and exudates

ArticleYear
Treatment of acute Nipah encephalitis with ribavirin.
    Annals of neurology, 2001, Volume: 49, Issue:6

    Topics: Adult; Asian People; China; Encephalitis, Viral; Female; Humans; Malaysia; Male; Paramyxovirinae; Retrospective Studies; Ribavirin; Treatment Outcome; Treatment Refusal

2001
Effects of ribavirin and hydroxyurea on oral infection of Aedes aegypti (L.) with dengue virus.
    The Southeast Asian journal of tropical medicine and public health, 2012, Volume: 43, Issue:6

    Topics: Aedes; Animals; Antiviral Agents; Dengue; Dengue Virus; Female; Humans; Hydroxyurea; Insect Vectors; Malaysia; Ribavirin; Virus Replication

2012
Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin Regimen for Patients Infected With Chronic Hepatitis C Virus Genotype 1 in Malaysia.
    Value in health regional issues, 2020, Volume: 21

    Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cost-Benefit Analysis; Cyclopropanes; Genotype; Hepatitis C; Humans; Lactams, Macrocyclic; Malaysia; Proline; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Valine

2020